Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01254370 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
A Phase 2 study, sponsored by Santen SAS.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT01254370: Completed Phase 2 study, sponsored by Santen SAS.
NCT01254370 is a Phase 2 study that has completed, run by Santen SAS. The registered enrollment target is 105 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01254370, a Phase 2 study, has completed, sponsored by Santen SAS.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
The purpose of this study is to compare: * the effect of Catioprost® and Travatan Z® on the ocular surface disease (OSD) in subjects with glaucoma or ocular hypertension and ocular surface disease. * the intraocular pressure (IOP) lowering effect and safety of Catioprost® and Travatan Z® in subjects with glaucoma or ocular hypertension and ocular surface disease.
Primary Outcome
Efficacy measures: * Change from baseline in Intraocular Pressure (IOP) * Change in Ocular Surface Disease (OSD)
Interventions
- DRUG Latanoprost
- DRUG Travatan Z
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
What the finished NCT01254370 record still lists
NCT01254370 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 2 interventions - of which Latanoprost is the first listed.
NCT01254370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01254370 about?
NCT01254370 is a clinical study titled "Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease". The purpose of this study is to compare: * the effect of Catioprost® and Travatan Z® on the ocular surface disease (OSD) in subjects with glaucoma or ocular hypertension and ocular surface disease. * the intraocular pressure (IOP) lowering effect and safety of Catioprost® and Travatan Z® in subject...
What is the current status of trial NCT01254370?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2010-11. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01254370?
The interventions under investigation include: Latanoprost (DRUG), Travatan Z (DRUG).
Who is sponsoring clinical trial NCT01254370?
This trial is sponsored by Santen SAS, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01254370's enrollment target sits among peer trials
105 650th of 2000 higher than 1,341 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia